Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64826 - 64850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	BRCA2	675	upregulated	resveratrol results in increased expression of BRCA2 mRNA	13q13.1	A23885
Resveratrol	Investigational	BRF1	2972	downregulated	resveratrol results in decreased expression of BRF1 mRNA	14q32.33	A22498 A23847
Resveratrol	Investigational	BST2	684	downregulated	resveratrol results in decreased expression of BST2 mRNA	19p13.11	A23886
Resveratrol	Investigational	BST2	684	upregulated	resveratrol results in increased expression of BST2 mRNA	19p13.11	A23852
Resveratrol	Investigational	BUB1	699	downregulated	resveratrol results in decreased expression of BUB1 mRNA	2q13	A23857
Resveratrol	Investigational	BUB1B	701	downregulated	resveratrol results in decreased expression of BUB1B mRNA	15q15.1	A23857
Resveratrol	Investigational	BUB1B	701	upregulated	resveratrol results in increased expression of BUB1B mRNA	15q15.1	A21103
Resveratrol	Investigational	BUB3	9184	upregulated	resveratrol results in increased expression of BUB3 mRNA	10q26.13	A22498
Resveratrol	Investigational	C3	718	upregulated	resveratrol results in increased expression of C3 mRNA	19p13.3	A23852
Resveratrol	Investigational	C4BPB	725	upregulated	resveratrol results in increased expression of C4BPB mRNA	1q32.1	A23852
Resveratrol	Investigational	CALR	811	downregulated	resveratrol results in decreased expression of CALR mRNA	19p13.13	A22498
Resveratrol	Investigational	CAMP	820	upregulated	resveratrol results in increased expression of CAMP mRNA	3p21.31	A22328
Resveratrol	Investigational	CAP2	10486	downregulated	resveratrol results in decreased expression of CAP2 mRNA	6p22.3	A23859
Resveratrol	Investigational	CAPG	822	upregulated	resveratrol results in increased expression of CAPG mRNA	2p11.2	A23852
Resveratrol	Investigational	CAPN9	10753	upregulated	resveratrol results in increased expression of CAPN9 mRNA	1q42.2	A22289
Resveratrol	Investigational	CARD16	114769	upregulated	resveratrol results in increased expression of CARD16 mRNA	11q22.3	A23852
Resveratrol	Investigational	CASP1	834	upregulated	resveratrol results in increased expression of CASP1 mRNA	11q22.3	A23852
Resveratrol	Investigational	CASP10	843	upregulated	resveratrol results in increased expression of CASP10 mRNA	2q33.1	A23845
Resveratrol	Investigational	CASP2	835	upregulated	resveratrol results in increased expression of CASP2 mRNA	7q34	A23845 A23854
Resveratrol	Investigational	CASP3	836	downregulated	resveratrol results in decreased expression of CASP3 mRNA	4q35.1	A22498
Resveratrol	Investigational	CASP3	836	upregulated	resveratrol results in increased expression of CASP3 mRNA	4q35.1	A22498 A23847
Resveratrol	Investigational	CAT	847	upregulated	resveratrol results in increased expression of CAT mRNA	11p13	A23887 A23888 A23889 A23890
Resveratrol	Investigational	CBL	867	downregulated	resveratrol results in decreased expression of CBL mRNA	11q23.3	A23854
Resveratrol	Investigational	CCL11	6356	downregulated	resveratrol results in decreased expression of CCL11 mRNA	17q12	A23891
Resveratrol	Investigational	CCL2	6347	downregulated	resveratrol results in decreased expression of CCL2 mRNA	17q12	A20459 A20456 A20457 A23877 A22625 A23892

Displaying entries 64826 - 64850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability